BUZZ-Salix Pharmaceuticals Ltd: Valeant in talks to buy co - Bloomberg
** Drugmaker Salix's shares up 6 pct at $141.84 in afternoon trade
** Canadian drugmaker Valeant Pharmaceuticals is in talks to buy Salix, Bloomberg reports, quoting people with the knowledge of the matter (bloom.bg/1Da0N5B)
** British drugmaker Shire Plc also interested in Salix, Bloomberg says, citing sources
** The talks follow Salix saying it would restate financial results for the past seven quarters due to inventory problems that led to a management change
** U.S.-listed shares of Valeant down about 3 percent at $157.43 on the New York Stock Exchange
** Salix stock had gained 27.8 pct in 2014
© Thomson Reuters 2017 All rights reserved.